Evaluation of two GnRH-I based vaccine formulations on the testes function of entire Suffolk cross ram lambs

A modified GnRH peptide (CHWSYGLRPG-NH 2) was conjugated to tetanus toxoid (TT) or diphtheria toxoid (DT) and formulated with Quil A saponin or a sustained release injectible PLGA (poly(lactide- co-glycolide)/triacetin). For the Quil A formulations, two administrations of TT conjugate at 3-weekly in...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine Vol. 24; no. 16; pp. 3172 - 3183
Main Authors: Earl, Elizabeth R., Waterston, Mary M., Aughey, Elizabeth, Harvey, Michael J.A., Matschke, Christian, Colston, Angela, Ferro, Valerie A.
Format: Journal Article
Language:English
Published: Oxford Elsevier Ltd 12-04-2006
Elsevier
Elsevier Limited
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A modified GnRH peptide (CHWSYGLRPG-NH 2) was conjugated to tetanus toxoid (TT) or diphtheria toxoid (DT) and formulated with Quil A saponin or a sustained release injectible PLGA (poly(lactide- co-glycolide)/triacetin). For the Quil A formulations, two administrations of TT conjugate at 3-weekly intervals were followed by two booster injections with the DT conjugate in entire ram lambs. With the PLGA formulations, only two injections were administered; the first containing TT and the second DT at 6-weekly intervals. Evaluation was carried out by comparing the specific antibody levels produced in relationship to hormone profiles and testicular changes. The Quil A formulation was considered the most effective, as it caused significant reduction in testosterone and follicle stimulating hormone levels, resulting in marked suppression of spermatogenesis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-News-1
ObjectType-Feature-3
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2006.01.041